This aviation services leader reported a notable insider sale as shares continued to reflect strong performance over the past ...

SoFi Technologies (SOFI) was trading lower after an announcement on the exercise of underwriters' option to purchase shares ...

The founder of a mental health startup who's facing felony charges following an erratic episode at a Saratoga winery was ...

Over time, ESOPs have become a key pillar of startup compensation in India. However, Unacademy’s recent decision to sharply reduce the ESOP exercise window for former employees has forced many to ...

This Idaho exploration firm, focused on gold and antimony, reported a notable insider sale following a year of substantial ...

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that it ...

Devon Energy (DVN) has had unusual call option activity today, according to a Barchart report. Devon announced it will release Q4 earnings on Feb. 17, so investors may be expecting a dividend hike ...

Focused on rare liver disease therapies, this biopharma company reported a significant insider sale amid strong one-year stock gains.

This clinical-stage biotech focused on precision medicines reported significant insider selling, according to recent SEC filings.

Legence Corp. (Nasdaq: LGN) ('Legence”) today announced that the underwriters of the previously announced upsized secondary ...

As of Tuesday morning, Corcept Therapeutics shares are down by 0.59%, with a current price of $79.35. This implies that Belanoff's 550,000 shares have a value of $41,508,500.